From the University of Texas Southwestern Medical Center, Dallas, TX; Gynecologic Oncology Group Statistical and Data Center, Roswell Park Cancer Institute, Buffalo; Long Island Gynecologic Oncologists, Smithtown, NY; Dana-Farber Partners Cancer Care, Massachusetts General Hospital, Boston, MA; University of Oklahoma, Oklahoma City, OK; Abington Memorial Hospital, Rosenfeld Cancer Center, Abington, PA; University Hospital Case Medical Center, Cleveland, OH; and Virginia Commonwealth University, Richmond,...
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Driven by 2 papers. Top paper: “Phase II Evaluation of Pemetrexed in the Treatment of Recurrent or Persistent Platinum-Resistant Ovarian or Primary Peritoneal Carcinoma: A Study of the Gynecologic Oncology Group”.
John A. Blessing, Carolyn N. Krasner, Robert S. Mannel, Parviz Hanjani, Michael L. Pearl +5 more
Mario M. Leitão, D. Scott McMeekin, Linda Van Le, Jubilee Brown, Gregory P. Sutton +4 more